| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 145,50 | 146,90 | 09:13 | |
| 145,50 | 146,90 | 09:13 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Demystifying Align Technology: Insights From 6 Analyst Reviews | 4 | Benzinga.com | ||
| 07.01. | Here's What to Expect From Align Technology's Next Earnings Report | 5 | Barchart.com | ||
| 05.01. | Do You Believe in Align Technology's (ALGN) Growth Prospects? | 8 | Insider Monkey | ||
| 13.12.25 | Align Technology: Wenn der Markt zu lange skeptisch bleibt | 24 | Investing.com Deutsch | ||
| 11.12.25 | Is Align Technology Stock Underperforming the S&P 500? | 6 | Barchart.com | ||
| 09.12.25 | ALGN Stock Rises on Thailand Launch of Invisalign With MAOB | 17 | Zacks | ||
| ALIGN TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 05.12.25 | Align Technology stock gains as competitor raises prices | 7 | Investing.com | ||
| 05.12.25 | Align Technology-Aktie legt zu - Konkurrent kündigt Preiserhöhung an | 14 | Investing.com Deutsch | ||
| 01.12.25 | Align Technology (ALGN) Slid as Demand Rebound Expectations Fell Short | 9 | Insider Monkey | ||
| 01.12.25 | Align Technology Strengthens Presence in South Africa with Innovative Digital Dentistry Solutions | 16 | TechAfrica News | ||
| 24.11.25 | Align Technology Stock: Analyst Estimates & Ratings | 18 | Barchart.com | ||
| 05.11.25 | ALIGN TECHNOLOGY INC - 10-Q, Quarterly Report | 5 | SEC Filings | ||
| 01.11.25 | Align Technology: Gemischte Quartalszahlen und Gegenwind am Markt erzwingen Restrukturierung | 28 | Investing.com Deutsch | ||
| 01.11.25 | Align Technology Q2 2025 slides: Mixed results prompt restructuring amid market headwinds | 13 | Investing.com | ||
| 30.10.25 | Why Align Technology Stock Popped Today | 20 | The Motley Fool | ||
| 30.10.25 | ALGN Stock Up on Q3 Earnings and Revenue Beat, Margins Crash | 6 | Zacks | ||
| 30.10.25 | Align Technology stock price target raised to $200 from $190 at Piper Sandler | 12 | Investing.com | ||
| 30.10.25 | Needham maintains Hold rating on Align Technology stock after Q3 beat | 10 | Investing.com | ||
| 30.10.25 | Align Technology: Leerink Partners hebt Kursziel auf 189 US-Dollar an | 11 | Investing.com Deutsch | ||
| 30.10.25 | Align Technology stock price target raised to $189 from $172 at Leerink | 4 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PAVMED | 11,970 | 0,00 % | Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? | ||
| SIEMENS HEALTHINEERS | 43,630 | 0,00 % | ANALYSE-FLASH: UBS hebt Ziel für Siemens Healthineers auf 51 Euro - 'Neutral' | ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat das Kursziel für Siemens Healthineers von 50 auf 51 Euro angehoben, aber die Einstufung auf "Neutral" belassen. Die Aktien der Bayern seien... ► Artikel lesen | |
| FRESENIUS | 47,640 | 0,00 % | ROUNDUP/Aktien Frankfurt Schluss: Kleines Dax-Plus - Chip-Ausrüster gesucht | FRANKFURT (dpa-AFX) - Optimistische Wachstumsprognosen des taiwanesischen Chip-Giganten TSMC haben den Aktien deutscher Zulieferer für die Chip-Industrie am Donnerstag kräftig Aufwind verliehen. Ansonsten... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 36,630 | 0,00 % | Elmos, FMC, Gerresheimer, Hensoldt, Hypoport, Zalando: Neue Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 35,200 | 0,00 % | Goldman setzt den Rotstift an: Carl Zeiss Meditec im Kurskeller: Analysten senken Kursziel drastisch | © Foto: Foto: ZEISSGoldman Sachs senkt das Kursziel für Carl Zeiss Meditec von 54 auf 42 Euro und stuft die Aktie auf "Neutral" herab. Ein schwaches erstes Quartal und strukturelle Probleme belasten... ► Artikel lesen | |
| HEARTFLOW | 33,550 | -1,87 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,060 | 0,00 % | Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic | MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR), a global structural heart company committed... ► Artikel lesen | |
| GENEDX | 100,04 | +0,36 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,450 | +0,28 % | Forecasting The Future: 6 Analyst Projections For Progyny | ||
| PRIVIA HEALTH GROUP | 23,600 | +1,68 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| RXSIGHT | 9,950 | 0,00 % | Expert Outlook: RxSight Through The Eyes Of 5 Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 39,210 | +1,24 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,300 | 0,00 % | Alignment Healthcare Named to the 2026 Fortune World's Most Admired Companies List for First Time | ||
| PROCEPT BIOROBOTICS | 30,940 | +2,08 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| UNITEDHEALTH | 296,80 | -0,27 % | Judge Tosses Drug Pricing Conspiracy Case Against CVS, UnitedHealth, Evernorth |